Compounds > ng-nitroarginine methyl ester

Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Renal Insufficiency

ng-nitroarginine methyl ester has been researched along with Renal Insufficiency in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (17.65)	18.2507
2000's	8 (47.06)	29.6817
2010's	5 (29.41)	24.3611
2020's	1 (5.88)	2.80

Authors

Authors	Studies
Daniel, J; Desvaux, M; Gardette, M; Garrivier, A; Gobert, A; Jubelin, G; Loukiadis, E; Marchal, T; Naïli, I; Pizza, M	1
Adedara, IA; Adeyemo, MO; Ajibade, TO; Alake, SE; Farombi, EO; Olajide, LO	1
Abdulla, MH; Abdullah, NA; Ahmad, Fu; Chia, TY; Johns, EJ; Kaur, G; Rathore, HA; Sattar, MA	1
Araki, S; Hanatani, S; Izumiya, Y; Kimura, Y; Ogawa, H; Rokutanda, T; Walsh, K	1
Chatsudthipong, V; Kongrat, S; Muanprasat, C; Srisawat, U	1
Agharazii, M; Bélanger, S; Larivière, R; Lebel, M; Lemieux, P; Therrien, F	1
Eräranta, A; Jolma, P; Kalliovalkama, J; Kurra, V; Moilanen, E; Mustonen, J; Myllymäki, J; Niemelä, O; Pörsti, I; Riutta, A; Tahvanainen, A; Vehmas, TI	1
Kobuchi, S; Matsumura, Y; Ohkita, M; Sugiura, T; Takaoka, M; Tanaka, R; Tsutsui, H; Yamagata, M; Yukimura, T	1
Grötsch, H; Hropot, M; Langer, KH; Linz, W; Wiemer, G	1
Alvarez-Rodríguez, A; Armendáriz-Borunda, J; Covarrubias, A; Grijalva, G; Islas-Carbajal, MC; Rincón-Sánchez, AR	1
Katayama, T; Kubo, Y; Kurata, H; Matsumura, Y; Ohkita, M; Takaoka, M; Takayama, J; Tsutsui, H	1
Jacob, HJ; Lazar, J; Provoost, AP; Specht, PA; van Dijk, SJ	1
Grötsch, H; Hropot, M; Klaus, E; Langer, KH; Linz, W; Schölkens, BA; Wiemer, G	1
Barefield, D; Ram, S; White, R; Work, J	1
Jacob, HJ; Provoost, AP; Van Dokkum, RP	1
Boztok, N; Can, C; Sen, S; Tuglular, I	1
Bautista, R; Escalante, B; Hernández, J; Oyekan, A; Sánchez, A	1

Other Studies

17 other study(ies) available for ng-nitroarginine methyl ester and Renal Insufficiency

Article	Year
Interplay between enterohaemorrhagic Emerging microbes & infections, 2020, Volume: 9, Issue:1 Topics: Animals; Bacterial Adhesion; Enterohemorrhagic Escherichia coli; Enzyme Inhibitors; Escherichia coli Infections; Female; Host-Pathogen Interactions; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide; Renal Insufficiency; Shiga Toxin; Virulence; Virulence Factors	2020
Taurine Ameliorates Thyroid Hypofunction and Renal Injury in L-NAME-Induced Hypertensive Rats. Drug research, 2019, Volume: 69, Issue:2 Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Dietary Supplements; Disease Models, Animal; Humans; Hypertension; Kidney; Male; NG-Nitroarginine Methyl Ester; Oxidative Stress; Rats; Rats, Wistar; Renal Insufficiency; Taurine; Thyroid Gland	2019
The effects of tempol on renal function and hemodynamics in cyclosporine-induced renal insufficiency rats. Renal failure, 2013, Volume: 35, Issue:7 Topics: Animals; Antioxidants; Blood Pressure; Cyclic N-Oxides; Cyclosporine; Disease Models, Animal; Hemodynamics; Hypertension; Kidney; Kidney Concentrating Ability; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Insufficiency; Spin Labels; Superoxide Dismutase	2013
Akt1-mediated fast/glycolytic skeletal muscle growth attenuates renal damage in experimental kidney disease. Journal of the American Society of Nephrology : JASN, 2014, Volume: 25, Issue:12 Topics: Adiponectin; Animals; Cytokines; Disease Models, Animal; Fibrosis; Glycolysis; Inflammation; Kidney; Mice; Mice, Transgenic; Muscle Proteins; Muscle, Skeletal; Muscles; Muscular Atrophy; Myofibroblasts; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Physical Conditioning, Animal; Proto-Oncogene Proteins c-akt; Renal Insufficiency; SKP Cullin F-Box Protein Ligases	2014
Losartan and Sodium Nitroprusside Effectively Protect against Renal Impairments after Ischemia and Reperfusion in Rats. Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:5 Topics: Adenosine Triphosphatases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Captopril; Ischemia; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroprusside; Peptides, Cyclic; Rats, Wistar; Renal Insufficiency; Reperfusion; Reperfusion Injury	2015
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. European journal of pharmacology, 2009, Apr-01, Volume: 607, Issue:1-3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrasentan; Blood Pressure; Endothelin-1; Hydralazine; Hypertension, Malignant; Losartan; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency	2009
Hyperuricemia, oxidative stress, and carotid artery tone in experimental renal insufficiency. American journal of hypertension, 2009, Volume: 22, Issue:9 Topics: Animals; Carotid Arteries; Creatinine; Dinoprost; Hyperuricemia; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Oxidative Stress; Oxonic Acid; Peroxides; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Uric Acid; Vasodilation	2009
Protective effect of 17β-estradiol on ischemic acute kidney injury through the renal sympathetic nervous system. European journal of pharmacology, 2012, May-15, Volume: 683, Issue:1-3 Topics: Animals; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Injections, Intravenous; Ischemia; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renal Veins; Reperfusion Injury; Sympathetic Nervous System; Synaptic Transmission; Tamoxifen	2012
Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats. Naunyn-Schmiedeberg's archives of pharmacology, 2003, Volume: 367, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biphenyl Compounds; Glomerular Filtration Rate; Heart; Hypertension; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Renal Insufficiency; Ventricular Fibrillation	2003
Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:1 Topics: Animals; Aspartate Aminotransferases; Creatinine; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Kidney; Liver; Liver Cirrhosis, Experimental; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Renal Insufficiency; RNA, Messenger; Sodium	2005
Protective effect of nitric oxide on ischemia/reperfusion-induced renal injury and endothelin-1 overproduction. European journal of pharmacology, 2005, Jul-11, Volume: 517, Issue:3 Topics: Animals; Dose-Response Relationship, Drug; Endothelin-1; Kidney; Kidney Function Tests; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; Protective Agents; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Reperfusion Injury; Time Factors	2005
Absence of an interaction between the Rf-1 and Rf-5 QTLs influencing susceptibility to renal damage in rats. Nephron. Experimental nephrology, 2006, Volume: 104, Issue:3 Topics: Albuminuria; Animals; Animals, Congenic; Blood Pressure; Enzyme Inhibitors; Epistasis, Genetic; Genetic Predisposition to Disease; Glomerulosclerosis, Focal Segmental; Homeostasis; Hypertension; Nephrectomy; NG-Nitroarginine Methyl Ester; Quantitative Trait Loci; Rats; Rats, Inbred Strains; Renal Circulation; Renal Insufficiency; Survival Analysis	2006
Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency. Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 350, Issue:6 Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Cardiomegaly; Cyclic GMP; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Wistar; Renal Insufficiency; Ventricular Fibrillation	1994
Peritoneal dialysis solutions reverse the hemodynamic effects of nitric oxide synthesis inhibitors. Kidney international, 1995, Volume: 48, Issue:6 Topics: Animals; Arginine; Dialysis Solutions; Enzyme Inhibitors; Hemodynamics; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peritoneal Dialysis; Rats; Rats, Sprague-Dawley; Renal Insufficiency	1995
Genetic differences define severity of renal damage after L-NAME-induced hypertension in rats. Journal of the American Society of Nephrology : JASN, 1998, Volume: 9, Issue:3 Topics: Animals; Autopsy; Blood Pressure; Body Weight; Creatinine; Glomerulosclerosis, Focal Segmental; Humans; Hypertension, Renal; Incidence; Infant; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred Strains; Regression Analysis; Renal Insufficiency; Severity of Illness Index; Species Specificity; Survival; Systole	1998
Protective effect of oral L-arginine administration on gentamicin-induced renal failure in rats. European journal of pharmacology, 2000, Mar-03, Volume: 390, Issue:3 Topics: Administration, Oral; Animals; Arginine; Creatinine; Enzyme Inhibitors; gamma-Glutamyltransferase; Gentamicins; Kidney; Lithium; Male; NG-Nitroarginine Methyl Ester; Rats; Renal Insufficiency; Sodium; Urination	2000
Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:3 Pt 2 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acid; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Insufficiency; RNA, Messenger; Vasodilation	2001